PIM
Penobscot Investment Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,000
| Closed | -$207K | – | 315 |
|
|
2024
Q2 | $207K | Hold |
1,000
| – | – | 0.02% | 299 |
|
|
2024
Q1 | $271K | Hold |
1,000
| – | – | 0.03% | 265 |
|
|
2023
Q4 | $236K | Buy |
+1,000
| New | +$236K | 0.03% | 268 |
|
|
2023
Q3 | – | Sell |
-1,000
| Closed | -$210K | – | 273 |
|
|
2023
Q2 | $210K | Hold |
1,000
| – | – | 0.03% | 223 |
|
|
2023
Q1 | $202K | Hold |
1,000
| – | – | 0.04% | 223 |
|
|
2022
Q4 | $218K | Buy |
+1,000
| New | +$218K | 0.04% | 216 |
|
|
2022
Q3 | – | Sell |
-1,000
| Closed | -$214K | – | 220 |
|
|
2022
Q2 | $214K | Hold |
1,000
| – | – | 0.04% | 217 |
|
|
2022
Q1 | $284K | Hold |
1,000
| – | – | 0.04% | 208 |
|
|
2021
Q4 | $377K | Hold |
1,000
| – | – | 0.05% | 189 |
|
|
2021
Q3 | $413K | Hold |
1,000
| – | – | 0.06% | 179 |
|
|
2021
Q2 | $370K | Hold |
1,000
| – | – | 0.05% | 185 |
|
|
2021
Q1 | $290K | Hold |
1,000
| – | – | 0.05% | 197 |
|
|
2020
Q4 | $250K | Hold |
1,000
| – | – | 0.04% | 192 |
|
|
2020
Q3 | $226K | Buy |
+1,000
| New | +$226K | 0.04% | 191 |
|